Skip to main content
SpringerLink
Log in

Stroke Models for Preclinical Trials of Neuroprotective Agents

  • Chapter
  • First Online:
Book cover Emerging Strategies in Neuroprotection

Part of the book series: Advances in Neuroprotection ((AN,volume 22))

Abstract

With advances in the understanding of the pathophysiology of ischemic brain injury, several therapeutic regimens have been conceived to protect the brain during or following ischemic insult. Despite the numerous claims of therapeutic success in animal models in the past two decades, no therapeutic agents have been approved by the Food and Drug Administration (FDA) for patients with acute ischemic stroke in the United States (Pulsinelli and Buchan, 1989). Lack of success in extrapolating therapeutic efficacy in animal models to stroke patients has raised concern about the validity of using animal stroke models to develop therapeutic regimens (Wiebers et al., 1990). Several recent editorials have extensively discussed the pros and cons of animal stroke models (Graham, 1988; Molinari, 1988; Wiebers et al., 1990; Zivin and Grotta, 1990). An important issue, i.e., the quality of animal trials, however, has not been adequately addressed previously and will be the main focus of this review.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abramson NS, Safar P, Detre KM, Kelsey SF, Monroe J, Reinmuth OM, Snyder JV (1986): Brain resuscitation clinical trial I study group: Randomized clinical study of theopental loading in comatose survivors of cardiac arrest. N Engl J Med 314: 397–403.

    Article  Google Scholar 

  • Asano T, Gotoh O, Koide T, Takadura K (1985): Ischemic brain edema following occlusion of the middle cerebral artery in the rat. II. Alteration of the eicosanoid synthesis profile of brain microvessels. Stroke 16: 110

    Article  CAS  Google Scholar 

  • Boxer PA, Cordon JJ, Mann ME, Rodolosi LC, Vartanian MG. Rock DM, Talor CP, Marcoux FW (1990): Comparison of phenytoin with noncompetitive Nmethyl-D-aspartate antagonists in a model of focal brain ischemia in rat. Stroke 21: III 47–51

    Google Scholar 

  • Brint S, Jacewicz M, Kiessling M, Tanabe J, Pulsinelli W (1988): Focal brain ischemia in the rat: Methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab 8: 474–485

    Article  CAS  Google Scholar 

  • Buchan A, Pulsinelli WA (1990): Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. Neuroscience 10 (1): 311–316

    Article  CAS  Google Scholar 

  • Busto R, Dietrich WD, Globus MY, Valdes I, Scheinberg P, Ginsberg MD (1987): Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 7 (6): 729–736

    Article  CAS  Google Scholar 

  • Chen ST, Hsu CY, Hogan EL, Macriq H, Balentine JD (1986): A model of focal ischemic stroke in the rat: Reproducible extensive cortical infarction. Stroke 17: 738–743

    Article  CAS  Google Scholar 

  • Ginsberg MD, Castella Y, Dietrich WD, Watson BD, Busto R (1989): Acute thrombotic infarction suppresses metabolic activation of ipsilateral somatosensory cortex: Evidence for functional diaschisis. J Cereb Blood Flow Metab 9: 329–337

    Article  CAS  Google Scholar 

  • Globus MY, Busto R, Dietrich WD, Martinez E, Valdes I, Ginsberg, MD (1988): Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and ry-amniobutyric acid studied by intracerebral microdialysis. J Neurochem 51: 1455–1460

    Article  CAS  Google Scholar 

  • Gotoh O, Asano T, Koide T, Takakura K (1985): Ischemic brain edema following occlusion of the middle cerebral artery in the rat. I. The time courses of the brain water, sodium and potassium contents and blood-brain barrier permeability to 1251-albumin. Stroke 16: 101–110

    Article  CAS  Google Scholar 

  • Graham DI (1988): Focal cerebral infarction. J Cereb Blood Flow Metab 8: 769–773

    Article  CAS  Google Scholar 

  • Hsu CY, Faught RE Jr, Furlan BM, Coull BM, Huang DC, Hogan EL, Linet OI, Yatus FM for Prostacyclin Study Group (1987): Intravenous prostacyclin in acute nonhemorrhagic stroke: A placebo-controlled double-blind trial. Stroke 18: 352–358

    Article  Google Scholar 

  • Hsu CY, Norris JW, Hogan EL, Bladin P, Dinsdale HB, Yatsu FM, Earnest MP, Scheinberg P, Caplan LR, Karp HR, Swanson PD, Feldman RG, Cohen MM, Mayman CI, Cobert B, Savitsky JP for Pentoxifylline Study Group (1988): Pentoxifylline in acute nonhemorrhagic stroke: A randomized, placebo-controlled double-blind trial. Stroke 19: 716–722

    Article  Google Scholar 

  • Jacewicz M, Brint S, Tanabe J, Pulsinelli WA (1990): Continuous nimodipine treatment attenuates cortical infarction in rat subjected to 24 hours of focal cerebral ischemia. J Cereb Blood Flow Metab 10: 89–96

    Article  CAS  Google Scholar 

  • Jensen ML, Auer RN (1988): The NMDA antagonist ketamine fails to protect against ischaemic neuronal necrosis in the rat. Br J Anaesth 61: 206–212

    Article  CAS  Google Scholar 

  • Karpiak SE, Tagliavia A, Wakade CG (1989): Animal models for the study of drugs in ischemic stroke. Annu Rev Pharmacol Toxicol 29: 403–414

    Article  CAS  Google Scholar 

  • Kushner M, Nencini P, Reivich M, Rango M, Jamieson D, Fazekas F, Zimmerman R, Chawluk J, Alavi A, Alves W (1990): Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome. Ann Neurol 28: 129–135

    Article  CAS  Google Scholar 

  • Levy DE, Brierly JB (1979): Delayed pentobarbital administration limits ischemic brain damage in gerbils. Ann Neurol 5: 59–67

    Article  CAS  Google Scholar 

  • Liu TH, Beckman JS, Freeman BA, Hogan EL, Hsu CY (1989): Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol 256: H589–H593

    CAS  PubMed  Google Scholar 

  • Marcoux FW, Goodrich JE, Dominick MA (1988): Ketamine prevents ischemic neuronal injury. Brain Res 452: 329–335

    Article  CAS  Google Scholar 

  • Michenfelder JD, Milde JH (1975): Influence of anesthetics on metabolics, functional and pathological responses to regional cerebral ischemia. Stroke 6: 405–412

    Article  CAS  Google Scholar 

  • Molinari GF (1986): Experimental models of ischemic stroke. In: Stroke, Pathophysiology, Diagnosis, and Management, Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eds. New York: Churchill Livingstone, pp 57–73

    Google Scholar 

  • Molinari GF (1988): Why model strokes? Stroke 19: 1197–1203

    Article  Google Scholar 

  • Myers RE, Yamaguchi S (1977): Nervous system effects of cardiac arrest in monkeys. Arch Neurol 34: 65–73

    Article  CAS  Google Scholar 

  • Nakayama H., Ginsberg MD, Dietrich WD (1988): s-Emopamil, a novel calcium channel blocker and serotonin SZ antagonist, markedly reduces infarct size following middle cerebral artery occlusion in the rat. Neurology 38: 1667–1673

    Article  CAS  Google Scholar 

  • Pulsinelli WA, Brierly JB (1979): A new model of bilateral hemisphereal ischemia in the unanesthetized rat. Stroke 10: 267–272

    Article  CAS  Google Scholar 

  • Pulsinelli WA, Buchan A (1989): The utility of animal ischemia models in predicting pharmacotherapeutic response in the clinical setting. In: Cerebrovascular Diseases, Ginsberg MD, Dietrich WD, eds. New York: Raven Press, pp 87–91

    Google Scholar 

  • Reimer KA, Jennings RB, Cobb FR, Murdock RH, Greenfield Jr JC, Becker LC, Bulkley BH, Hutchins GM, Schwartz Jr RP, Bailey KR, Passamani ER (1985): Animal models for protecting ischemic myocardium: Results of the NHLBI Cooperative Study. Circ Res 56: 651–665

    Article  CAS  Google Scholar 

  • Schallert T, Jones TA, Linder MD (1990): Multilevel transneuronal degeneration after brain damage: Behavioral events and effects of anticonvulsant -y-aminobutyric acid-related drugs. Stroke 21: III 143–146

    Google Scholar 

  • Volpe BT, Davis HP (1989): An approach to the functional analysis of an animal model of ischemic injury. In: Cerebrovascular Diseases, Ginsberg MD, Dietrich WD, eds. New York: Raven Press, pp 335–340

    Google Scholar 

  • Waltz AG (1979): Clinical relevance of models of cerebral ischemia. Stroke 10: 211–218

    Article  CAS  Google Scholar 

  • Weiss J, Goldberg MP, Choi DW (1986): Ketamine protects cultured neocortical neurons from hypoxic injury. Brain Res 380: 186–192

    Article  CAS  Google Scholar 

  • Wiebers BO, Adams HP Jr, Whisnant JP (1990): Animal models of stroke: Are they relevant to human disease? Stroke 21: 1–5

    Article  CAS  Google Scholar 

  • Yip PK, He YY, Hsu CY, Garg N, Marangos P, Hogan EL (1991): Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion. Neurology 41: 899–905

    Article  CAS  Google Scholar 

  • Zivin JA, Grotta JC (1990): Animal stroke models: They are relevant to human disease. Stroke 21: 981–983

    Article  CAS  Google Scholar 

  • Zivin JA, Fisher M, DeGivolami U, Hemeway CG, Stashak JA (1985): Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 230: 1289–1292

    Article  ADS  CAS  Google Scholar 

Download references

Authors
  1. Chung Y. Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yong Y. He
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Teng N. Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Grace Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paul J. Marangos
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. NeuroTherapeutics Corp. and Center for Neurologic Study, 11211 Sorrento Valley Road, 92121, San Diego, CA, USA

    Paul J. Marangos

  2. Department of Pharmacology, Texas College of Osteopathic Medicine, 3500 Camp Bowie Boulevard, 76107, Fort Worth, TX, USA

    Harbans Lal

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Birkhäuser Boston

About this chapter

Cite this chapter

Hsu, C.Y., He, Y.Y., Lin, T.N., Wu, G., Marangos, P.J. (1992). Stroke Models for Preclinical Trials of Neuroprotective Agents. In: Marangos, P.J., Lal, H. (eds) Emerging Strategies in Neuroprotection. Advances in Neuroprotection, vol 22. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4684-6796-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-6796-3_3

  • Published:

  • Publisher Name: Birkhäuser, Boston, MA

  • Print ISBN: 978-1-4684-6798-7

  • Online ISBN: 978-1-4684-6796-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation